A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products-Reference-Cited by-同舟云学术

A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products

Published:2022-09 Issue: Volume:219 Page:114955
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Jain Mohit,Khan Shahnawaz

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference37 articles.

1. Cariprazine for the treatment of schizophrenia: a review of this dopamine D3-preferring D3/D2 receptor partial agonist;Citrome;Clin. Schizophr. Relat. Psychoses,2016

2. Review of cariprazine in management of psychiatric illness;Campbell;Ment. Health Clin.,2018

3. Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel;Fagiolini;Ann. Gen. Psychiatry,2020

4. M.b Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia;Earley;Int. Clin. Psychopharmacol.,2017

5. Highlights of prescribing information for VRAYLAR™ (cariprazine) capsules. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204370lbl.pdf.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient and environmentally friendly spectrofluorimetric determination of cariprazine: An analytical and green chemistry approach;Luminescence;2024-08

2. Analysis of omarigliptin forced degradation products by ultra‐fast liquid chromatography, mass spectrometry, and in vitro toxicity assay;Biomedical Chromatography;2024-05-29